The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Akeso Biopharma; AstraZeneca; GlaxoSmithKline; Mersana; MSD; Novocure; Roche; Sotio
Anastomotic leakage following bowel resection in radical cytoreductive surgery for ovarian cancer: A subgroup analysis of the prospective AGO-OVAR.OP3/LION.
 
Bastian Czogalla
No Relationships to Disclose
 
Fabian Trillsch
Honoraria - AstraZeneca; Clovis Oncology; Eisai; MSD Oncology; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Eisai Germany; Immunogen; MSD Oncology; Roche; Tesaro/GSK
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Immunogen; Tesaro/GSK
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche Belgium; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer Germany; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Verena Loidl
No Relationships to Disclose
 
Alexander Reuss
No Relationships to Disclose
 
Andreas Du Bois
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline/Tesaro; Mersana; Novartis; Roche/Genentech; Zodiac Pharma
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - Alkermes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Francesco Raspagliesi
No Relationships to Disclose
 
Werner Meier
No Relationships to Disclose
 
David Cibula
No Relationships to Disclose
 
Alexander Mustea
No Relationships to Disclose
 
Ingo B. Runnebaum
Consulting or Advisory Role - GlaxoSmithKline
 
Barbara Schmalfeldt
No Relationships to Disclose
 
Giovanni Damiano Aletti
No Relationships to Disclose
 
Rainer Kimmig
No Relationships to Disclose
 
Giovanni Scambia
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Speakers' Bureau - Clovis Oncology; MSD
 
Felix Hilpert
Honoraria - AstraZeneca; Clovis Oncology; MSD; Novartis; Novartis; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Tesaro
 
Annette Hasenburg
Honoraria - AstraZeneca; Celgene; GlaxoSmithKline; LEO Pharma; MedConcept; Medicultus Kassel; Pfizer; Promedicis ; Roche; SoftConsultGroup; Streamedup!; Tesaro
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/MSD; LEO Pharma; PharmaMar; Promedicis; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; MedConcept
 
Uwe Wagner
No Relationships to Disclose
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)